Multiple Department of Pathology faculty members have recently been recognized for their achievements and nominated to leadership roles for their excellence within their respective fields. These members continue to demonstrate the depth of our department's knowledge and research.
It is with great pleasure that we introduce Dr. Annette Kim, Division Director for Molecular and Genomic Pathology and Clinical Professor of Pathology, effective July 1, 2023. Dr. Kim is a nationally and internationally recognized leader in her field, with a remarkable track record of accomplishment in clinical practice, education, and discovery.
The Department of Pathology offers the Molecular and Cellular Pathology Graduate Program (MCP) for students who are interested in translational research – the step between basic science research and clinical care, the “bench-to-bedside” transition. Sahiti Marella is a graduate student in the MCP who was recently awarded her first F31 grant. This is an NIH-funded predoctoral grant that provides awardees with a monthly stipend to support tuition and fees, and funds for training-related costs while they conduct their PhD research project, for up to five-years of funding.
Dr. Chen Yang joined the faculty of the Michigan Medicine Departments of Pathology and Pediatrics in a joint recruitment effort in July 2020. He serves as the associate director of the Clinical Cytogenetics Lab (Pathology) and MMGL Molecular Genetics Lab (Pediatrics). Yang’s appointment is rather unique in that he has a 50% appointment in each department. Usually, faculty have a primary appointment in one department and a secondary “dry” appointment in another department.
12:00 pm EST
Join #UMichPath and SOPHiA Genetics for a virtual event with department faculty Dr. Noah Brown, who will be hosting a discussion related to developing an NGS solution in order to keep pace with the ever-evolving recommendations and clinical guidelines for myeloid malignancies.
Congratulations to Dr. Thomas Giordano and the entire Cancer Genome Atlas Project team for winning the American Association of Cancer Research's 2020 Team Science Award [...]
The research was just published in Modern Pathology and highlights the importance of next-generation sequencing within oncogenic roles for P53 and JAK/STAT signaling in microcystic adnexal carcinomas.
The research was just published in Histopathology and features prominent contributions from our faculty.
The Department of Pathology 2019 Annual Report is now available online. Our department continues to show outstanding performance and growth and the past year was another example of why our department is one of the best in the world.
In the report, you will read about [...]
Drs. Thomas Giordano, Paul Harms, and Dafydd Thomas have a fully staffed and highly functional Research Histology lab. The laboratories lead technician, Chelsea Decker, HT, has been keeping the lab [...]
In 2015, Felipe da Veiga Leprevost, PhD, came to the University of Michigan as a research fellow to study computational proteomics. In June of 2019, he accepted a faculty position as a Research Investigator in Bioinformatics. He now has a Michigan-born little one and his roots are growing deeper in Ann Arbor [...]
A new study finds that U-M-designed compounds led to significantly smaller, slower-growing tumors.
The 10th annual CHAMP Research Day will be held on Thursday, February 7th, 2019 from 3:00 pm to 7:30 pm in the Research Auditorium located in building 10 of the North Campus Research Complex. The event will feature presentations by Department of Pathology trainees and faculty [...]
On Thursday, December 20, 2018, at 3:30 pm, the founders of InheRET, Inc., participated in the bell ringing ceremony at the University of Michigan’s Technology Transfer office. The event signaled the formal licensing of technology developed at the University of Michigan to the spin-off corporation.
InheRET, Inc., developed jointly by the Department of Pathology and the Department of Internal Medicine faculty and staff, has produced an online family health history questionnaire. It interprets patient-entered data [...]
Commitments to patient care and innovative technologies earn us top ratings.
A decade-long effort to genomically characterize multiple cancers begets a huge archive.